Company / Free Cash Flow
IDEAYA Biosciences, Inc. Free Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$73.5M
FY2025
5-year range
-$251.4M / $55.0M
FY2021-FY2025
Trend
+70.8%
vs FY2024
Sector context
#93 of 194
Health Care
What the data says
At -$73M, IDEAYA Biosciences, Inc.'s free cash flow ranks #93 of 194 in the Health Care sector. Free Cash Flow returned to growth in FY2025 after 2 years of decline, reaching -$73M.
Based on SEC 10-K filings.
-$73M in FY2025.
Improved from -$118M to -$73M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 194 in Health CareTop 48% of 194This company -$73.5M Sector average $470.8M
▼
-115.6% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 70.8% year-over-year.
- Ranks #93 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2022.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$73.5M | +70.8% |
| FY2024 | -$251.4M | -113.8% |
| FY2023 | -$117.6M | -313.9% |
| FY2022 | $55.0M | +235.2% |
| FY2021 | -$40.7M | -38.7% |
| FY2020 | -$29.3M | +27.9% |
| FY2019 | -$40.7M | -38.7% |
| FY2018 | -$29.3M | -109.8% |
| FY2017 | -$14.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026